Exodus Point Capital Management, LP Pyxis Oncology, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 114,387 shares of PYXS stock, worth $395,779. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114,387
Previous 89,471
27.85%
Holding current value
$395,779
Previous $381,000
0.52%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PYXS
# of Institutions
86Shares Held
28.5MCall Options Held
134KPut Options Held
5K-
Deep Track Capital, LP Greenwich, CT4.18MShares$14.5 Million0.45% of portfolio
-
Laurion Capital Management LP New York, NY3.86MShares$13.4 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$9.64 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.56MShares$8.87 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$7.13 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $121M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...